SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tracks how ILARIS works in everyday care for rare inflammatory diseases
Disease control Recruiting nowThis study looks at how patients with Familial Mediterranean Fever (FMF) or Still's disease (including juvenile and adult forms) are treated with the drug canakinumab (ILARIS) in real-world clinics across Europe and Israel. Researchers will track 160 people who have been on the d…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
New pill could ease severe arthritis in kids as young as 1
Disease control Recruiting nowThis study tests whether baricitinib, a daily pill, is safe and works for children aged 1 to 17 with systemic juvenile idiopathic arthritis (sJIA), a severe inflammatory condition. Some children receive baricitinib, while others get a standard injected drug (tocilizumab) for comp…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 08:52 UTC